Sponsored by:

Nuclear Medicine: Page 437

Draxis to emphasize radiopharmaceuticals
By AuntMinnie.com staff writers
July 18, 2000
ADAC, Hitachi expand relationship
By AuntMinnie.com staff writers
July 17, 2000
Cytogen taps Hoffman as CFO
July 10, 2000
FDA finds Palatin’s LeuTech agent safe and effective
By AuntMinnie.com staff writers
July 10, 2000
Marconi signs deal with Consorta
By AuntMinnie.com staff writers
July 9, 2000
Cytogen to acquire Advanced Magnetics
By Erik L. Ridley
Radiopharmaceutical developer Cytogen moved to broaden its position in the oncology market today, announcing an agreement to acquire MRI contrast agent firm Advanced Magnetics in a stock swap valued at $60 million.
July 9, 2000
ADAC lands GPO deal with Novation
By AuntMinnie.com staff writers
July 5, 2000
Nuclear medicine researchers seek better prostate imaging with new gamma probe
By Shalmali Pal
A transrectal imaging probe being developed by researchers at the University of Michigan promises both high sensitivity and resolution for early detection of prostate cancer, according to a presentation at the Society of Nuclear Medicine meeting in June.
July 5, 2000
Y 364small
Cytogen applies for European clearance of ProstaScint
By AuntMinnie.com staff writers
June 25, 2000
Vital Imaging Companies buys CTI PET scanners
By AuntMinnie.com staff writers
June 21, 2000
Syncor appoints Boone to head division
By AuntMinnie.com staff writers
June 20, 2000
Investigational and standard nuclear exams show mettle in detecting emboli
By Shalmali Pal
Researchers who used a new radiopharmaceutical called DMP-444 to test for deep venous thrombosis declared it a success; another group found ventilation-perfusion scanning superior to electron beam CT for detecting pulmonary embolism.
June 20, 2000
Previous Page
Page 437 of 444
Next Page